Affymax, Inc. CEO Arlene Morris Joins Nuon Therapeutics Inc.'s Board of Directors as Chair

Published: Jul 16, 2009

SAN MATEO, Calif.--(BUSINESS WIRE)--Nuon Therapeutics, Inc., a clinical stage, privately-held biopharmaceutical company focused on novel therapies for autoimmune and inflammatory diseases, announced today that Arlene Morris, president and CEO of Affymax, Inc. (Nasdaq:AFFY), has been elected chairperson of the company’s Board of Directors. A proven commercial leader in the biotechnology and pharmaceutical industry with more than 25 years of experience, Ms. Morris is well suited to work with the management team at Nuon Therapeutics.

Back to news